Company

Rapport Therapeutics

https://www.rapportrx.com/

Industryclinical-stage biotechnology company leveraging the science of receptor-associated proteins (RAPs) for neuromedicines

Funding raised

CompanyRoundDate
Rapport TherapeuticsSeries B Funding2023-08-23